Hematology/Oncology Annadel Medical Group Vice Chair, Breast Cancer Leadership Program
Oncology
Dr. Jarrod P. Holmes, MD
|
|
Give Review
Jarrod Holmes works in the field of Oncology. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care Jarrod Holmes is a published doctor and has 19 publications published. The lastest was: 'Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: From US Military Cancer Institute Clinical Trials Grou...' He accepts Medicare.
Publications
- Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast Cancer recurrence in high-risk patients: From US Military Cancer Institute Clinical Trials Grou...
- Use of booster inoculations to sustain the clinical effect of an adjuvant breast Cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and...
- Folate receptor α: A storied past and promising future in immunotherapy.
- Clinical and immunologic responses of HLA-A3+ breast Cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial.
- Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast Cancer patients: United States Military Cancer Institute Clin...
- The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
- Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate Cancer patients.
- Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast Cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01...
- Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.
- Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast Cancer patients: U.S. Military Cancer Institute Clinic...
- Quantification and phenotypic characterization of circulating tumor Cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cance...
- AE37: a novel T-cell-eliciting vaccine for breast Cancer.
- Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast Cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide.
- Comparison of different HER2/neu vaccines in adjuvant breast Cancer trials: implications for dosing of peptide vaccines.
- Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from U...
- Use of GM-CSF as an adjuvant with Cancer vaccines: beneficial or detrimental?
- CD4+ T Cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37).
- The E75 HER2/neu peptide vaccine.
Schools
Duke University
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Naval Medical Center -
Duke University School of Medicine
Drug Facts
| NPI NUMBER | 1013018035 | |
| NPPES Provider LastName | HOLMES | |
| NPPES Provider FirstName | JARROD | |
| NPPES Provider ZIPCode | 954031757 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 896.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 83.0 | |
| Percent Opioid Claims | 9.26 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013018035 |
| Last Name Of The Provider | HOLMES |
| First Name Of The Provider | JARROD |
| View All |
Similar Doctors
|
|
Dr. Leroy Wayne Keiser, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ian C. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary Nichols, MD |
|
|
Dr. Julius M. Jaffe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Warr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marek Bozdech, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shafqat M. Akhtar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry B. Richardson Jr., MD |
|
|
Dr. Mark Turrill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheri S. Quincy, DO |